Serina Therapeutics, Inc.SERNYSE
LOADING
|||
Switch Symbol:
Year-over-year revenue growth rate
| Period | Value |
|---|---|
| Q3 2025 | -100.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 100.00% |
| Q4 2024 | -200.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | -100.00% |
| Q1 2024 | -99.84% |
| Q4 2023 | 10544.83% |
| Q3 2023 | 0.00% |
| Q2 2023 | -100.00% |
| Q1 2023 | 275.00% |
| Q4 2022 | -11.11% |
| Q3 2022 | -25.00% |
| Q2 2022 | 140.00% |
| Q1 2022 | 150.00% |
| Q4 2021 | -91.67% |
| Q3 2021 | -35.14% |
| Q2 2021 | -33.93% |
| Q1 2021 | -88.91% |
| Q4 2020 | 16.36% |
| Q3 2020 | 4.83% |
| Q2 2020 | -19.61% |
| Q1 2020 | -6.19% |
| Q4 2019 | 33.58% |
| Q3 2019 | 8.16% |
| Q2 2019 | 0.00% |
| Q1 2019 | -100.00% |
| Q4 2018 | -17.63% |
| Q3 2018 | -18.10% |
| Q2 2018 | 94.14% |
| Q1 2018 | -47.82% |
| Q4 2017 | 21.49% |
| Q3 2017 | 24.83% |
| Q2 2017 | 13.11% |
| Q1 2017 | 0.00% |